NL-OMON36729
Withdrawn
Not Applicable
18F-fluoride PET-scan as complementary diagnostic medium for patients with otosclerosis - A pilot study - 18F-fluoride PET-scan for otosclerosis
Medisch Universitair Ziekenhuis Maastricht0 sites40 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- fixation of the stapes
- Sponsor
- Medisch Universitair Ziekenhuis Maastricht
- Enrollment
- 40
- Status
- Withdrawn
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Otosclerosis patients:
- •\* fenestral otosclerosis
- •\* cochlear otosclerosis;Control patients:
- •\* Clinically relevant reason to undergo a PET/CT\-scan with 18F\-fluorine, in which the head \& neck region is scanned as part of the protocol. The indication for the scan will be set by the nuclear specialist and the referring specialist.
Exclusion Criteria
- •Otosclerosis patients:
- •\* Prior ear surgery at the concerning ear
- •\* Chronic otitis media or chronic mastoiditis
- •\* Tympanosclerosis diagnosed at previous ear surgery
- •\* Claustrophobia or the inability to lie still during the scan
- •\* Active malignancy
- •\* Generalised bone condition (except osteoporosis)
- •\* Pregnancy or lactation
- •\* Patient refuses to be notified about additional findings on the PET\-scan;Control patients:
- •\* A history of ear surgery, with the exception of ear grommets
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
se of a PET scan to quantify disease activity in patients with hearing loss due to otosclerosis.Onderwerp:- Keel-, neus- en oorheelkunde- Otosclerose (fenestraal en cochleolabyrinthair) - PET/CT-beeldvormingSubject:- Otorhinolaryngology- Otosclerosis (fenestral and cochlear)- PET/CT imagingNL-OMON21643INITIATOR: J.J. WatervalP. Debyelaan 25Postbus 58006202 AZ Maastricht(T) +31-(0)433876543(E) J.Waterval@gmail.com40
Active, not recruiting
Phase 1
18F-fluoride PET for Early Non-invasive Assessment of Cortical Bone Formation - Non-invasive Assessment of Cortical Bone Formation - Version 1EUCTR2009-016523-61-GBKing’s College London30
Active, not recruiting
Phase 1
A bone scan in combination with some specific blood samples for the classification of bone disease in patients suffering from chronic kidney disease.Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD), especially renal osteodystofi.MedDRA version: 20.0 Level: LLT Classification code 10065404 Term: Combined positron emission tomogram and computerised tomogram System Organ Class: 10022891 - InvestigationsMedDRA version: 20.0 Level: SOC Classification code 10022891 Term: Investigations System Organ Class: 10022891 - InvestigationsMedDRA version: 20.0 Level: LLT Classification code 10066622 Term: Chronic hemodialysis System Organ Class: 100000004865Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]EUCTR2016-005160-34-DKniversitetsklinikken for Nyresygdomme og Blodtryksforhøjelse, Regionshospitalet Holstebro, Hospitalsenheden Vest40
Recruiting
Not Applicable
[18F]Fluoride PET-CT imaging for detection and monitoring of bone formation in spondyloarthritisNL-OMON52517Vrije Universiteit Medisch Centrum48
Active, not recruiting
Phase 1
Detection and monitoring of effects of biological therapy on bone formation in patients with Bechterew's disease or psoriatic arthritis with the use of a Positron Emission Tomography (PET) scan.Spondyloarthritis (ankylosing spondylitis and psoriatic arthritis)Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2017-004850-40-NLVU Medical Center, department of Rheumatology48